Agilent Technologies Inc. (A)
undefined
undefined%
At close: undefined
136.43
0.14%
After-hours Jan 06, 2025, 07:00 PM EST

Agilent Technologies Inc. Revenue Breakdown

Quarter Oct 31, 2024Jul 31, 2024Apr 30, 2024Jan 31, 2024Oct 31, 2023Jul 31, 2023Apr 30, 2023Jan 31, 2023Oct 31, 2022Jul 31, 2022Apr 30, 2022Jan 31, 2022Oct 31, 2021Jul 31, 2021Apr 30, 2021Jan 31, 2021Oct 31, 2020Jul 31, 2020Apr 30, 2020Jan 31, 2020Oct 31, 2019Jul 31, 2019Apr 30, 2019Jan 31, 2019Oct 31, 2018Jul 31, 2018Apr 30, 2018Jan 31, 2018Oct 31, 2017Jul 31, 2017Apr 30, 2017Jan 31, 2017Oct 31, 2016Jul 31, 2016Apr 30, 2016Jan 31, 2016Oct 31, 2015Jul 31, 2015Apr 30, 2015Jan 31, 2015Oct 31, 2014Jul 31, 2014Apr 30, 2014Jan 31, 2014Oct 31, 2013Jul 31, 2013Apr 30, 2013Jan 31, 2013Oct 31, 2012Jul 31, 2012Apr 30, 2012Jan 31, 2012
Agilent CrossLab Revenue 426.00M 411.00M 402.00M 405.00M 404.00M 396.00M 387.00M 381.00M 381.00M 359.00M 353.00M 359.00M 572.00M 560.00M 536.00M 532.00M 518.00M 463.00M 449.00M 470.00M 476.00M 467.00M 455.00M 442.00M 441.00M 426.00M 426.00M 408.00M 404.00M 386.00M 378.00M 363.00M 370.00M 360.00M 346.00M 344.00M 178.00M 336.00M 321.00M 331.00M 612.00M 592.00M 577.00M 591.00M 1.09B 163.00M 166.00M 163.00M 296.00M 106.00M 469.00M 461.00M
Agilent CrossLab Revenue Growth +3.65% +2.24% -0.74% +0.25% +2.02% +2.33% +1.57% 0.00% +6.13% +1.70% -1.67% -37.24% +2.14% +4.48% +0.75% +2.70% +11.88% +3.12% -4.47% -1.26% +1.93% +2.64% +2.94% +0.23% +3.52% 0.00% +4.41% +0.99% +4.66% +2.12% +4.13% -1.89% +2.78% +4.05% +0.58% +93.26% -47.02% +4.67% -3.02% -45.92% +3.38% +2.60% -2.37% -45.93% +570.55% -1.81% +1.84% -44.93% +179.25% -77.40% +1.74% n/a
Diagnostics and Genomics Revenue 442.00M 385.00M 417.00M 407.00M 356.00M 349.00M 362.00M 342.00M 352.00M 340.00M 358.00M 339.00M 341.00M 346.00M 315.00M 294.00M 294.00M 241.00M 263.00M 249.00M 269.00M 263.00M 254.00M 235.00M 302.00M 237.00M 219.00M 185.00M 210.00M 197.00M 201.00M 164.00M 193.00M 180.00M 178.00M 158.00M n/a 167.00M 169.00M 148.00M n/a n/a n/a n/a n/a 401.00M 405.00M 401.00M 261.00M 391.00M n/a n/a
Diagnostics and Genomics Revenue Growth +14.81% -7.67% +2.46% +14.33% +2.01% -3.59% +5.85% -2.84% +3.53% -5.03% +5.60% -0.59% -1.45% +9.84% +7.14% 0.00% +21.99% -8.37% +5.62% -7.43% +2.28% +3.54% +8.09% -22.19% +27.43% +8.22% +18.38% -11.90% +6.60% -1.99% +22.56% -15.03% +7.22% +1.12% +12.66% n/a n/a -1.18% +14.19% n/a n/a n/a n/a n/a n/a -0.99% +1.00% +53.64% -33.25% n/a n/a n/a
Life Sciences and Applied Markets Revenue 833.00M 782.00M 754.00M 846.00M 928.00M 927.00M 968.00M 1.03B 1.12B 1.02B 896.00M 976.00M 747.00M 680.00M 674.00M 722.00M 671.00M 557.00M 526.00M 638.00M 622.00M 544.00M 529.00M 607.00M 551.00M 540.00M 561.00M 618.00M 575.00M 531.00M 523.00M 540.00M 548.00M 504.00M 495.00M 526.00M n/a 511.00M 473.00M 547.00M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Life Sciences and Applied Markets Revenue Growth +6.52% +3.71% -10.87% -8.84% +0.11% -4.24% -6.29% -7.44% +9.52% +13.73% -8.20% +30.66% +9.85% +0.89% -6.65% +7.60% +20.47% +5.89% -17.55% +2.57% +14.34% +2.84% -12.85% +10.16% +2.04% -3.74% -9.22% +7.48% +8.29% +1.53% -3.15% -1.46% +8.73% +1.82% -5.89% n/a n/a +8.03% -13.53% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Quarter Oct 31, 2024Oct 31, 2023Oct 31, 2022Oct 31, 2021Oct 31, 2020Oct 31, 2019Oct 31, 2018Oct 31, 2017Oct 31, 2016Oct 31, 2015Oct 31, 2014Oct 31, 2013Oct 31, 2012Oct 31, 2010
Americas Revenue 2.57B 2.73B 2.68B 2.40B 1.97B 1.86B 1.41B 1.31B 1.25B 1.21B 2.07B 2.04B 2.22B 1.76B
Americas Revenue Growth -5.82% +1.86% +11.56% +22.15% +5.75% +31.61% +7.61% +5.04% +3.73% -41.74% +1.32% -7.89% +26.02% n/a
Asia Pacific Revenue 2.17B 2.35B 2.47B 2.23B 1.93B 1.86B n/a n/a n/a n/a n/a n/a n/a n/a
Asia Pacific Revenue Growth -7.67% -4.86% +10.78% +15.51% +3.60% n/a n/a n/a n/a n/a n/a n/a n/a n/a
Europe Revenue 1.77B 1.75B 1.70B 1.69B 1.44B 1.44B n/a n/a n/a n/a n/a n/a n/a n/a
Europe Revenue Growth +0.91% +3.24% +0.65% +16.98% +0.14% n/a n/a n/a n/a n/a n/a n/a n/a n/a

Operating Expense Breakdown

Quarter Oct 31, 2024Jul 31, 2024Apr 30, 2024Jan 31, 2024Oct 31, 2023Jul 31, 2023Apr 30, 2023Jan 31, 2023Oct 31, 2022Jul 31, 2022Apr 30, 2022Jan 31, 2022Oct 31, 2021Jul 31, 2021Apr 30, 2021Jan 31, 2021Oct 31, 2020Jul 31, 2020Apr 30, 2020Jan 31, 2020Oct 31, 2019Jul 31, 2019Apr 30, 2019Jan 31, 2019Oct 31, 2018Jul 31, 2018Apr 30, 2018Jan 31, 2018Oct 31, 2017Jul 31, 2017Apr 30, 2017Jan 31, 2017Oct 31, 2016Jul 31, 2016Apr 30, 2016Jan 31, 2016Oct 31, 2015Jul 31, 2015Apr 30, 2015Jan 31, 2015
Selling, General, and Administrative Revenue 397.00M 395.00M 380.00M 393.00M 393.00M 407.00M 415.00M 419.00M 422.00M 412.00M 386.00M 417.00M 389.00M 403.00M 420.00M 407.00M 387.00M 347.00M 358.00M 404.00M 385.00M 366.00M 354.00M 355.00M 356.00M 339.00M 338.00M 341.00M 325.00M 308.00M 307.00M 289.00M 321.00M 310.00M 318.00M 304.00M 297.00M 290.00M 292.00M 310.00M
Selling, General, and Administrative Revenue Growth +0.51% +3.95% -3.31% n/a -3.44% -1.93% -0.95% -0.71% +2.43% +6.74% -7.43% +7.20% -3.47% -4.05% +3.19% +5.17% +11.53% -3.07% -11.39% +4.94% +5.19% +3.39% -0.28% -0.28% +5.01% +0.30% -0.88% +4.92% +5.52% +0.33% +6.23% -9.97% +3.55% -2.52% +4.61% +2.36% +2.41% -0.68% -5.81% n/a
Research and Development Revenue 111.00M 127.00M 113.00M 120.00M 114.00M 118.00M 126.00M 123.00M 119.00M 116.00M 115.00M 117.00M 116.00M 113.00M 109.00M 103.00M 102.00M 92.00M 197.00M 104.00M 102.00M 101.00M 99.00M 102.00M 104.00M 97.00M 91.00M 93.00M 89.00M 87.00M 84.00M 79.00M 84.00M 86.00M 81.00M 78.00M 82.00M 79.00M 81.00M 88.00M
Research and Development Revenue Growth -12.60% +12.39% -5.83% +5.26% -3.39% -6.35% +2.44% +3.36% +2.59% +0.87% -1.71% +0.86% +2.65% +3.67% +5.83% +0.98% +10.87% -53.30% +89.42% +1.96% +0.99% +2.02% -2.94% -1.92% +7.22% +6.59% -2.15% +4.49% +2.30% +3.57% +6.33% -5.95% -2.33% +6.17% +3.85% -4.88% +3.80% -2.47% -7.95% n/a

Create Price Alert on A

Your price alert will notify you when the stock price is above 136.24.

Add to Watchlist